Heron Therapeutics reported $149.13M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
ALKERMES ALKS:US 291.54M 634K
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amarin AMRN:US $ 0M 0M
Arrowhead Research ARWR:US $ 0 0
Eisai 4523:JP Y 84905M 9988M
Emergent Biosolutions EBS:US $ 793.6M 7.9M
Esperion Therapeutics ESPR:US $ 259.08M 402K
GlaxoSmithKline GSK:LN 18784M 10442M
Insmed INSM:US $ 807.11M 447K
JAZZ PHA JAZZ:US $ 5990M 2.87M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Omeros OMER:US $ 314.36M 454K
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Surmodics SRDX:US $ 0M 0M
Teva Pharmaceutical Industries TEVA:US $ 20363M 477M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Veracyte VCYT:US $ 0.6M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M